A practical migration guide for pharma teams moving from EPCIS 1.2 to EPCIS 2.0 - covering what changes, what stays, and how to sequence the transition without disrupting DSCSA compliance.
Blog
Top 25 EPCIS Data Errors That Break Interoperability
The 25 most common EPCIS data errors causing DSCSA interoperability failures - from schema mismatches to missing business steps - and the prevention controls that stop them.
DSCSA Deadline Map by Trading Partner Type (and What Changes After the Exemptions End)
A clear breakdown of every DSCSA enforcement deadline by trading partner type - manufacturers, wholesalers, large and small dispensers - and what happens when exemptions end.
DSCSA in 2026: Full Electronic Interoperability Across Digital Transformation and Daily Operations
This article focuses on DSCSA from an operational execution perspective, how interoperability behaves inside daily warehouse, quality, and supply chain workflows.
Whitepaper: NDC12 – Revising the National Drug Code Format and Drug Label Barcode Requirements for the U.S. Market
This white paper blends the original high-level summary with a more detailed narrative, offering both clear structure and practical depth. It explains the new NDC format, explores stakeholder impacts, describes the implications for GTIN, and outlines concrete next steps and emerging solution options.
